Hoth Therapeutics (HOTH) said Wednesday its board approved the purchase of up to $1 million in bitcoin.
"As bitcoin continues to grow, gaining investor attention and acceptance as a major and primary asset class, we believe that bitcoin will serve as a strong treasury reserve asset," Hoth Chief Executive Robb Knie said.
The biopharmaceutical company's shares were up 7.3% in recent trading.
Price: 0.88, Change: +0.06, Percent Change: +7.33
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。